DAMASCUS, Md. – September 30, 2015 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased research and awareness for sarcoma, a rare cancer of the connective tissue, today announced that it has initiated a fundraising campaign to support the genotyping of sarcoma patient tumors in collaboration with Memorial Sloan Kettering Cancer Center (MSK). Tumor genotyping is the process by which a sample of the patient’s tumor is evaluated for genetic abnormalities that may drive healthy cells to become tumor cells, creating a growing tumor.  If the tumor genotyping identifies a genetic abnormality that is potentially treatable by an…  Read More »